Elevations in parathyroid hormone (PTH) levels, known as secondary hyperparathyroidism (SHPT), is one of the most critical complications of CKD, leading, among other various consequences, to vascular calcification, cardiovascular diseases, and death, especially in CKD patients receiving hemodialysis [4]. This evidence concerns the gene PTH and chronic kidney disease.